Product News: American Cyanamid's rotavirus vaccine
Executive Summary
American Cyanamid's rotavirus vaccine: American Home Products applies Feb. 21 to divest American Cyanamid's human rotavirus vaccine research to Korea Green Cross to comply with the Federal Trade Commission's consent order approving the merger of AHP and American Cyanamid ("The Pink Sheet" Nov. 14, 1994, p. 11). Korea Green Cross also will be "the exclusive distributor in Korea of any oral rotavirus vaccine developed as a result of AHP's human rotavirus vaccine research program," AHP's application states. The public comment period on AHP's application will conclude March 25...